Delirium prevention in terminal cancer: Assessment of a multicomponent intervention

Psycho-Oncology

Volumn 21, Issue 2, 2012, Pages 187-194

  Gagnon, Pierre ^a,b,c,d   Allard, Pierre ^e   Gagnon, Bruno ^f   Mérette, Chantal ^d   Tardif, François ^a,c  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c Maison Michel Sarrazin   (Canada)

^d CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

delirium; monitoring; multicomponent intervention; oncology; palliative care; terminal cancer

Indexed keywords

AGED; ARTICLE; CANCER PATIENT; CONFUSION; CONTROLLED STUDY; DELIRIUM; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; PALLIATIVE THERAPY; RATING SCALE; TERMINAL CARE; TERMINAL DISEASE;

EID: 84856240962     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1881     Document Type: Article

References (37)

1. Pereira J, Hanson J, Bruera E,. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 1997; 79 (4): 835-842. (Pubitemid 27076350)
2. Lawlor PG, Gagnon B, Mancini IL, et al,. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 2000; 160 (6): 786-794. (Pubitemid 30165239)
3. Bruera E, Miller L, McCallion J, Macmillan K, Krefting L, Hanson J,. Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage 1992; 7 (4): 192-195.
4. Minagawa H, Uchitomi Y, Yamawaki S, Ishitani K,. Psychiatric morbidity in terminally ill cancer patients. A prospective study. Cancer 1996; 78 (5): 1131-1137. (Pubitemid 26284881)
5. Pantilat SZ,. End-of-life care for the hospitalized patient. Med Clin North Am 2002; 86 (4): 749-770, viii.
6. Casarett DJ, Inouye SK,. Diagnosis and management of delirium near the end of life. Ann Intern Med 2001; 135 (1): 32-40. (Pubitemid 32619281)
7. Gagnon P, Allard P, Masse B, DeSerres M,. Delirium in terminal cancer: a prospective study using daily screening, early diagnosis, and continuous monitoring. J Pain Symptom Manage 2000; 19 (6): 412-426. (Pubitemid 30447367)
8. Breitbart W, Gibson C, Tremblay A,. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 2002; 43 (3): 183-194. (Pubitemid 34522528)
9. Lawlor PG, Bruera ED,. Delirium in patients with advanced cancer. Hematol Oncol Clin North Am 2002; 16 (3): 701-714. (Pubitemid 34827376)
10. Lawlor PG,. The panorama of opioid-related cognitive dysfunction in patients with cancer: a critical literature appraisal. Cancer 2002; 94 (6): 1836-1853. (Pubitemid 34241124)
11. Bruera E, Macmillan K, Hanson J, MacDonald RN,. The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain 1989; 39 (1): 13-16. (Pubitemid 19258904)
12. Bruera E, Fainsinger RL, Miller MJ, Kuehn N,. The assessment of pain intensity in patients with cognitive failure: a preliminary report. J Pain Symptom Manage 1992; 7 (5): 267-270.
13. Marcantonio ER, Juarez G, Goldman L, et al,. The relationship of postoperative delirium with psychoactive medications. JAMA 1994; 272 (19): 1518-1522. (Pubitemid 24340794)
14. Schor JD, Levkoff SE, Lipsitz LA, et al,. Risk factors for delirium in hospitalized elderly. J Am Med Assoc 1992; 267 (6): 827-831.
15. Fleishman SB, Lesko LM, Breitbart W., Treatment of organic mental disorders in cancer patients. In Psychiatric Aspects of Symptom Management in Cancer Patients, Breitbart W, Hollamd JC, (eds). American Psychiatric Press: Washington, 1993.
16. Gagnon P, Charbonneau C, Allard P, Soulard C, Dumont S, Fillion L,. Delirium in advanced cancer: a psychoeducational intervention for family caregivers. J Palliat Care 2002; 18 (4): 253-261.
17. Leipzig RM, Goodman H, Gray G, Erle H, Reidenberg MM,. Reversible, narcotic-associated mental status impairment in patients with metastatic cancer. Pharmacology 1987; 35 (1): 47-54. (Pubitemid 17100960)
18. de Stoutz ND, Tapper M, Fainsinger RL,. Reversible delirium in terminally ill patients. J Pain Symptom Manage 1995; 10 (3): 249-253.
19. Caraceni A, Martini C, De Conno F, Ventafridda V,. Organic brain syndromes and opioid administration for cancer pain. J Pain Symptom Manage 1994; 9 (8): 527-533.
20. de Stoutz ND, Bruera E, Suarez-Almazor M,. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 1995; 10 (5): 378-384.
21. Inouye SK, Bogardus Jr ST, Charpentier PA, et al,. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999; 340 (9): 669-676. (Pubitemid 29110750)
22. Williams MA, Ward SE, Campbell EB,. Confusion: testing versus observation. J Gerontol Nurs 1988; 14 (1): 25-30.
23. Williams MA,. Delirium/acute confusional states: evaluation devices in nursing. Int Psychogeriatr 1991; 3 (2): 301-308.
24. Smith MJ, Breitbart WS, Platt MM,. A critique of instruments and methods to detect, diagnose, and rate delirium. J Pain Symptom Manage 1995; 10 (1): 35-77.
25. Oken MM, Creech RH, Tormey DC, et al,. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5 (6): 649-655. (Pubitemid 13149996)
26. Gaudreau JD, Gagnon P,. Psychotogenic drugs and delirium pathogenesis: the central role of the thalamus. Med Hypotheses 2005; 64 (3): 471-475. (Pubitemid 40023004)
27. Dai YT, Lou MF, Yip PK, Huang GS,. Risk factors and incidence of postoperative delirium in elderly Chinese patients. Gerontology 2000; 46 (1): 28-35.
28. Gaudreau JD, Gagnon P, Harel F, Roy MA, Tremblay A,. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 2005; 23 (27): 6712-6718. (Pubitemid 46190266)
29. Gaudreau JD, Gagnon P, Roy MA, Harel F, Tremblay A,. Association between psychoactive medications and delirium in hospitalized patients: a critical review. Psychosomatics 2005; 46 (4): 302-316. (Pubitemid 41472628)
30. Houts PS, Rusenas I, Simmonds MA, Hufford DL,. Information needs of families of cancer patients: a literature review and recommendations. J Cancer Educ 1991; 6 (4): 255-261.
31. Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E,. Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing. J Pain Symptom Manage 2001; 22 (2): 672-687. (Pubitemid 32725810)
32. Korte W, de Stoutz N, Morant R,. Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: short-and long-term experiences in a prospective study of 39 patients. J Pain Symptom Manage 1996; 11 (3): 139-146. (Pubitemid 26090589)
33. Cherny NI, Portenoy RK,. Cancer pain management. Current strategy. Cancer 1993; 72 (Suppl 11): 3393-3415. (Pubitemid 23357983)
34. Dillon C, Lopez J, Leyba C,. Oxazepam cost-savings conversion. Hosp Pharm 2001; 36 (6): 639-644.
35. Siddiqi N, Stockdale R, Britton AM, Holmes J,. Interventions for preventing delirium in hospitalised patients. Cochrane Database Syst Rev 2007; 2:CD005563.
36. Leung JM, Sands LP, Wang Y, et al,. Apolipoprotein E e4 allele increases the risk of early postoperative delirium in older patients undergoing noncardiac surgery. Anesthesiology 2007; 107 (3): 406-411. (Pubitemid 47329538)
37. Fong HK, Sands LP, Leung JM,. The role of postoperative analgesia in delirium and cognitive decline in elderly patients: a systematic review. Anesth Analg 2006; 102 (4): 1255-1266.